Tanya Labonne

Details

Role Laboratory Manager / Research Assistant

Research area Stem Cell Medicine

Group Immune Development

Stolper, J, Voges, HK, See, M, Mehdiabadi, NR, Chahal, G, Drvodelic, M, Eichenlaub, M, Labonne, T, Schultz, BG, Hidalgo, A, et al. The human FLT1 regulatory element directs vascular expression and modulates angiogenesis pathways in vitro and in vivo. 2026
view publication
Ng, ES, Sarila, G, Li, JY, Edirisinghe, HS, Saxena, R, Sun, S, Bruveris, FF, Labonne, T, Sleebs, N, Maytum, A, et al. Long-term engrafting multilineage hematopoietic cells differentiated from human induced pluripotent stem cells.. Nat Biotechnol 43(8) : 1274 -1287 2025
view publication
Saxena, R, Maytum, A, Labonne, T, Sarila, G, Inguanti, C, Edirisinghe, H, Stanley, E, Ng, E, Elefanty, A. 3157 – RUNX1 EXPRESSION TRACKS HUMAN HEMATOPOIESIS FROM HEMOGENIC ENDOTHELIUM TO HEMATOPOIETIC STEM CELLS. Experimental Hematology 137: 104478 2024
view publication
Saxena, R, Elefanty, A, Labonne, T, Ng, E, Stanley, E. 3170 – TRACKING DEVELOPMENT OF RUNX1+ HEMOGENIC ENDOTHELIUM IN VITRO. Experimental Hematology 124: s134 2023
view publication
Ng, E, Li, J, Saxena, R, Edirisinghe, H, Sarila, G, Bruveris, F, Sun, S, Labonne, T, Calvanese, V, Capellera-Garcia, S, et al. 2014 – MULTI-LINEAGE ENGRAFTMENT OF INDUCED HEMATOPOIETIC STEM CELLS (IHSCS) DIFFERENTIATED FROM HUMAN PLURIPOTENT STEM CELLS. Experimental Hematology 111: s38 2022
view publication